Real Decreto 726/1982, de 17 de marzo, por el que se regula la caducidad y devoluciones de las especialidades farmacéuticas a los laboratorios farmacéuticos. | BOE-A-1982-9070 — Spain law | Esheria

Real Decreto 726/1982, de 17 de marzo, por el que se regula la caducidad y devoluciones de las especialidades farmacéuticas a los laboratorios farmacéuticos.

This article defines the validity period and expiry date for pharmaceutical products, and says the preparing laboratory proposes the expiry date to the Directorate General of Pharmacy and Medicines, which decides after a prior opinion from the National Center of Pharmacobiology.

AI-assisted research synopsis — verify against the official legal text below.

Jurisdiction
Spain
Instrument
Regulation
Citation
BOE-A-1982-9070
Version
Undated source snapshot
Language
es
Updated
Official source
View official record ↗
company name changes dispensing distribution distribution controls distribution timing drug distribution drug expiry dates expiration labeling expired products expiry dates expiry dating expiry restrictions imports inventory segregation labeling medicine returns payment terms pharmaceutical labeling pharmaceutical packaging pharmaceutical products pharmaceutical products compliance pharmaceutical storage pharmacy operations pharmacy products +11 more

Statute overview

About this statute

Las partes pueden fijar libremente el plazo máximo de pago de los ejemplares devueltos, salvo que acuerden otra cosa; si no hay pacto distinto, las devoluciones anuales no pueden superar ciertos límites. This provision says the Royal Decree also applies to pharmaceutical specialty importers, certain acquirers of registration rights, and registration holders in company-name-change cases. This article classifies certain conduct as minor, serious, or very serious faults. Breaches of this Royal Decree are sanctioned under Royal Decree 2826/1977, which also applies to the pharmaceutical distribution and dispensing entity. This article defines the validity period and expiry date for pharmaceutical products, and says the preparing laboratory proposes the expiry date to the Directorate General of Pharmacy and Medicines, which decides after a prior opinion from the National Center of Pharmacobiology.